Extending dosing intervals reduces deadly side effect risk from multiple sclerosis drug

(NYU Langone Health / NYU School of Medicine) A commonly-prescribed multiple sclerosis (MS) infusion medication, natalizumab, linked to a rare but serious side effect is safer to use when dosing intervals are extended, according to a new study led by MS specialists at NYU Langone Health.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news